Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Micron’s AI Memory Capacity Fully Booked Through 2026

Robert Sasse by Robert Sasse
November 27, 2025
in AI & Quantum Computing, Nasdaq, Semiconductors, Tech & Software
0
Micron Stock
0
SHARES
19
VIEWS
Share on FacebookShare on Twitter

Memory chip manufacturer Micron Technology has delivered a significant announcement during the Thanksgiving period, revealing that its entire production capacity for High Bandwidth Memory (HBM)—a critical component powering advanced artificial intelligence systems—is completely sold out through the end of 2026. This positions the company with a substantial revenue buffer for the coming two years, even as competitors vie for market position. Following a recent share price decline, could this news provide the catalyst for a year-end rally?

Strong Recovery and Technical Resistance

After experiencing what traders described as a “flash crash” in mid-November—where shares plummeted 23% over several days, falling below the $200 threshold—Micron’s stock has demonstrated a remarkable rebound. The equity has since reclaimed its 50-day moving average and now faces its next significant technical resistance level at $257. Market analysts suggest that a decisive break above this barrier could potentially open a path toward new all-time highs.

Investment firm Morgan Stanley has identified even greater upside potential, setting a price target of $338, which represents substantial appreciation from current trading levels. The company’s upcoming quarterly earnings report, scheduled for December 17, will serve as the next critical test for investor confidence. Until then, the “sold out” production narrative is expected to provide sustained positive momentum.

Should investors sell immediately? Or is it worth buying Micron?

S&P Global Upgrades Outlook on AI Dominance

In a significant mid-week development, rating agency S&P Global revised its assessment of Micron from “stable” to “positive,” while maintaining the company’s BBB- investment-grade rating. This optimistic shift stems from Micron’s commanding position in the AI memory market, where its next-generation HBM products are proving transformative.

Company representatives confirmed that not only is current HBM3E production fully allocated, but upcoming HBM4 technology is also completely pre-sold. Addressing recent speculation about developmental delays, Micron clarified the HBM4 timeline: initial sample deliveries are scheduled for early 2026, with volume production commencing in the second half of the year.

Concurrently, the company’s gross profit margin is approaching 50%, a level not seen since 2018. This margin expansion is largely attributable to a strategic shift in revenue composition, with over 56% of sales now generated from the higher-margin data center business segment.

Ad

Micron Stock: Buy or Sell?! New Micron Analysis from February 7 delivers the answer:

The latest Micron figures speak for themselves: Urgent action needed for Micron investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Micron: Buy or sell? Read more here...

Tags: Micron
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Diginex Stock
Blockchain

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Next Post
Nvidia Stock

Nvidia's AI Dominance Faces Critical Test as Key Client Explores Alternatives

Novo Nordisk Stock

Novo Nordisk Shares Stage Impressive Rebound on Triple Positive News

QuantumScape Stock

QuantumScape Shares Face Mounting Pressure

Recommended

CRWD stock news

Tower Research Capital LLC TRC Demonstrates Unwavering Confidence in CrowdStrike Holdings as Cybersecurity Leader

2 years ago
Efficiently Reporting an Absence on WalmartOne: A Step-by-Step Guide for Employees

Beacon Announces Interim Chief Financial Officer

2 years ago

Alaska Airlines Boeing 737 Investigation Missing Bolts and Safety Measures

2 years ago

Impressive Financial Performance for Kiniksa Pharmaceuticals

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Trending

Universal Insurance Stock
Analysis

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

by Rodolfo Hanigan
February 7, 2026
0

Universal Insurance Holdings has reaffirmed its commitment to shareholder returns, declaring its regular quarterly dividend despite a...

Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts
  • Camping World’s New Leadership Faces First Major Test

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com